Antimicrobial Activities of Piperacillin-Tazobactam against Haemophilus influenzae Isolates, Including β-Lactamase-Negative Ampicillin-Resistant and β-Lactamase-Positive Amoxicillin- Clavulanate-Resistant Isolates, and Mutations in Their Quinolone Resistance-Determining Regions

β-Lactamase-negative ampicillin-resistant (BLNAR) isolates of Haemophilus influenzae have been emerging in some countries, including Japan. The Clinical and Laboratory Standards Institute has only a susceptible MIC breakpoint (≤1 μg/ml) for piperacillin-tazobactam and a disclaimer comment that BLNAR...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hirakata, Yoichi, Ohmori, Kaori, Mikuriya, Miwako, Saika, Takeshi, Matsuzaki, Kaoru, Hasegawa, Miyuki, Hatta, Masumitsu, Yamamoto, Natsuo, Kunishima, Hiroyuki, Yano, Hisakazu, Kitagawa, Miho, Arai, Kazuaki, Kawakami, Kazuyoshi, Kobayashi, Intetsu, Jones, Ronald N., Kohno, Shigeru, Yamaguchi, Keizo, Kaku, Mitsuo
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2009
Sujets:
Susceptibility
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764172/
https://ncbi.nlm.nih.gov/pubmed/19651910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00192-09
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires